{"name":"Alzinova AB","slug":"alzinova-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALZ-101","genericName":"ALZ-101","slug":"alz-101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALZ-101","genericName":"ALZ-101","slug":"alz-101","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZDdJQzM1SjF2d3FxbkpNeXVlRVNWQUprVksxLVQ4dF9QWW9JYml6TFpSbkQ5a25LT0FDcmpTdTdTWl9zY29wUEtRZlJFeG5mTE1xeDZGR0p6N2ZuVDBUeFdpcWJjV3BaX0FrZVFBLW5ocHN2UC16bGcxZXpXazZDR3l5Z0FzUUFkb3ltQUt5NzYwVVgxUkFFVHREd3hHTzI5RGd4YmIzUGc?oc=5","date":"2026-03-25","type":"pipeline","source":"TradingView","summary":"Alzinova publishes year-end report 2025 - TradingView","headline":"Alzinova publishes year-end report 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPWFdtUzJ4VUE1NlFGajItamtseXhnRHc1X3BoNG1pcktsNnhVWngyS2gyUGxlcm1sSVQwOHpocFBhZmxENy16ajNOY2RlcndyUU1RUXZwZmxmcThYcjRvMUFxeUs2NHRRRWtSVUYxdHg1UlptTGtBYS1kbHJBSnQ1MFc2VzhYZFo0czJKWklRSGt0Uk80WVhNZm9VV0poSTYxNl80YzljTlVMbUFJemQ1dXZrcVVMTnhSdWRHSmVJbkZSQ0ZnQzgyeGhvTFZFQ0ZQTjRSRzBnUFUyTzZPX1duX0xieFhBSzJHTVdkUkgzSWktZw?oc=5","date":"2026-01-19","type":"deal","source":"TradingView","summary":"Alzinova advanced partner discussions at the J.P. Morgan Healthcare Conference in San Francisco - TradingView","headline":"Alzinova advanced partner discussions at the J.P. Morgan Healthcare Conference in San Francisco","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPd3QyQ0JRbGF1TWJBNGZBTXJRWnV1a1hHVGgwcG5DUUFfMmZGYmlYQnpab3ZBVDhkQlU4cVpOdzZpcHd6NWFPbHhJMkkwcGtDbmQ3c0xUSk1kX055NXN1QzNvbzI3Um1BQ3U2WVlWWWtWUzRZWlBob09CdENuZm4zcGRQdThqbFRZNFNBeXBldVpNZTdWMl9tMmRiMHpHMFA4NnZWblRQTVJVMXhScjRjUXVuUmdBYjFBcDA3djNOaXJ5emNId29xN21VRE16SVk0RDhWcFNfR2NQV3pDUy1fLXBWLWZMRFYyOHYxYzJpa1VEWUtlRVpPNUdSRUxraUZESzhPWEZPdHVCNFRLVTdSbG9icUJaQWhyS050WjNzckRFaWpIYWF3cjVUWjQ4dkZUYTlCRlBadjNadHl4OXJtLXQ5dDJnVmc2?oc=5","date":"2025-07-08","type":"pipeline","source":"GlobeNewswire","summary":"Alzheimer’s Therapeutics Market on Upward Trajectory Across - GlobeNewswire","headline":"Alzheimer’s Therapeutics Market on Upward Trajectory Across","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNdTlUVV9UQ0M2bmowemt4UVFrZHlSbzRpMlZ0dnFfNVdOaTEwb1lPNnNiaHFYZFV5TVBJclBuT2dnZU9OeXhqV2Vtc2NabVpSZXY2bXdNblFvR2t2Sl93MGF0bkgxbzJCblZhWUxuckZXdTlxZExlQ2RiRGtHakNpU3dqNG5uaG4yNkUwYVVDM3hxVW1fbDdGdUdSRGxGanl3aHd1cmE2cWJuaUhOSlBtc242M2VnWnpFRm9EdGJLeGJNWk5EbWRWb19yWW9ob2g5T2dFRjNINlNRYm1fTG41dmxIWU9WQkxhUlJpVGZXcjY3enRJR1liTVIzcXZjZFVSTFVVbWp2alhuOXVLc1oyZ1dQajZlRWptMTVOTHdyRE02YWV1RWNNWXV3c1pxWjVmMXRjM3pubmthc0p5ZEVvMkpkOWZaZlB3TlE?oc=5","date":"2025-04-29","type":"trial","source":"GlobeNewswire","summary":"Phenylketonuria Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Phenylketonuria Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOU1d0ZnpQRW9kcEZ3dVdhdDNhc2FpZmRXSXFpeUpsNi1ZZVduZ1lRSGdfb1drRU4tMERkSWZvZGhJRW0yQmxtSEVzeEI3UWtTbDN4a3l5UnYtbXJKeEZFdWt0U21mVXZOSVBaNWxNQ2VTMk5BMjZwVWIxcHVxMnREaUZKb3c3cUpObU9BeTVKV3Y4THBOOUwyYzlQWnVKa1FQLUNjQ2hQd2tpREp1QzhhWnFuMTFNQjN4aVA5eUJIV3B1T2IxNFNMTVZSTnZ3XzY2c2p0cUR6T2ZJbFBhTWpZR2xOdGVlVWRlRmh5WkRqQWdmT3owU1dWakdRZ1J5VnR3bTVpaDB4WnljeHpvVm5UOHRtaE9Tc3g2WEd0eG5wZnhvMGZkNWk3WWI3TkJYRDM0VXJxdlhwSDZSMlk5emFGVmJJWUpubFluUHR5alVmVTk?oc=5","date":"2024-10-14","type":"trial","source":"GlobeNewswire","summary":"Tau Inhibitors Clinical Trial Pipeline Analysis - GlobeNewswire","headline":"Tau Inhibitors Clinical Trial Pipeline Analysis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}